Company: IXHL
Filing Date: 2025-02-14
Form Type: 10-Q
Source: 0001213900-25-013783
Chunk: 72

Company: Incannex Healthcare Inc.
Filing Date: 2025-02-14
Form: 10-Q
Item: Part I, Item 8
Chunk 72
---
 restated certificate of incorporation became effective, which provides for the issuance of 100,000,000
authorized shares of Common Stock with a par value of $0.0001 per share, with one vote per share. Holders of Common Stock are entitled
to receive any dividends as may be declared from time to time by the Company’s board of directors. 

On November 28, 2023, the Company effected the
Re-domiciliation. All references in these unaudited condensed consolidated financial statements to the Company’s outstanding Common
Stock, including per share information, have been retrospectively adjusted to reflect this Re-domiciliation.

Note 11 – Stock-based payments

    For the six months ended December 31, 

    2024
$  
    2023
$ 

    (in thousands) 
  
    Research and development 
     -  
     - 
  
    General and administrative 
     894  
     3,597 
  
    Total stock-based compensation expense 
     894  
     3,597 

    For the three months ended December 31, 

    2024
$  
    2023
$ 

    (in thousands) 
  
    Research and development 
     -  
     - 
  
    General and administrative 
     435  
     3,396 
  
    Total stock-based compensation expense 
     435  
     3,396 

Restricted stock units

A summary of the changes in the Company’s
restricted stock activity for the period ended December 31, 2024, are as follows:

    Numbers of  Shares  
    Weighted  Average Grant  Date Fair Value  $ 

    (in thousands,  expect per share data) 
  
    Unvested and Outstanding as of June 30, 2024 
     651,939  
     3.91 
  
    Granted 
     27,795  
     1.84 
  
    Vested 
     9,265  
     1.84 
  
    Forfeited 
     -  
     - 
  
    Unvested and Outstanding as of September 30, 2024 
     670,469  
     3.86 

    Numbers of  Shares  
    Weighted  Average Grant  Date Fair Value  $ 

    (